1-(4-Bromophenyl)-5-methyl-1H-1,2,3-triazole-4-carboxylic acid

Introduction

CAS No. :	20725-34-2	MDL No. :	MFCD02168482
Formula :	C10H8BrN3O2	Boiling Point :	No data available
Linear Structure Formula :	-	InChI Key :	FPTYOFQUENAVEO-UHFFFAOYSA-N
M.W :	282.09	Pubchem ID :	838349
Synonyms :

Physicochemical Properties

Num. heavy atoms :	16
Num. arom. heavy atoms :	11
Fraction Csp3 :	0.1
Num. rotatable bonds :	2
Num. H-bond acceptors :	4.0
Num. H-bond donors :	1.0
Molar Refractivity :	60.98
TPSA :	68.01 Ų

Pharmacokinetics

GI absorption :	High
BBB permeant :	Yes
P-gp substrate :	No
CYP1A2 inhibitor :	Yes
CYP2C19 inhibitor :	No
CYP2C9 inhibitor :	No
CYP2D6 inhibitor :	No
CYP3A4 inhibitor :	No
Log Kp (skin permeation) :	-6.39 cm/s

Lipophilicity

Log Po/w (iLOGP) :	1.82
Log Po/w (XLOGP3) :	2.3
Log Po/w (WLOGP) :	2.04
Log Po/w (MLOGP) :	1.99
Log Po/w (SILICOS-IT) :	1.48
Consensus Log Po/w :	1.92

Druglikeness

Lipinski :	0.0
Ghose :	None
Veber :	0.0
Egan :	0.0
Muegge :	0.0
Bioavailability Score :	0.56

Water Solubility

Log S (ESOL) :	-3.41
Solubility :	0.109 mg/ml ; 0.000385 mol/l
Class :	Soluble
Log S (Ali) :	-3.37
Solubility :	0.121 mg/ml ; 0.00043 mol/l
Class :	Soluble
Log S (SILICOS-IT) :	-3.16
Solubility :	0.193 mg/ml ; 0.000685 mol/l
Class :	Soluble

Medicinal Chemistry

PAINS :	0.0 alert
Brenk :	0.0 alert
Leadlikeness :	0.0
Synthetic accessibility :	2.11

Signal Word:	Warning	Class:
Precautionary Statements:	P261-P305+P351+P338	UN#:
Hazard Statements:	H302-H315-H319-H335	Packing Group:
GHS Pictogram:

Related View all 

• 

  Ghk-Cu

• 

  Gly-His-Lys acetate salt

• 

  N-Phenylacetyl-L-Prolylglycine ethyl ester

• 

  L-Phenylalanyl-L-isoleucine

• 

  L-Isoleucyl-L-phenylalanine

• 

  L-Ala-L-phe

• 

  L-Glutathione Reduced

• 

  L-Alanyl-L-tyrosine